The aim of our research division is to conduct studies in a variety of areas to advance the knowledge and practice of psychiatry, and includes epidemiological, diagnostic, treatment efficacy/safety, outcome, and medication utilization studies. Several of our clinicians have many years of experience in various areas of psychiatric research and continue to be involved in the conduction of research studies. In fact, some of our psychiatrists were active participants, through the Feighner Research Institute, in the development of many psychiatric medications currently FDA-approved and in common use for various psychiatric disorders.
In addition to independent research, PCSD~Feighner Research is conducting research in collaboration and partnership with academic institutions, pharmaceutical companies, medical groups, and managed care organizations.
PCSD~Feighner Research is the research division of PCSD, an integrated behavioral health group, which has been providing state of the art psychiatric and behavioral health services in San Diego County since 1972. PCSD is a behavioral health group with aproximately 100 clinicians and annual visits in excess of 150,000. PCSD~Feighner Research Institute was founded in 1972 by John Feighner, M.D., a pioneer in clinical psychopharmacology trials and a leader in biological psychiatry. Dr. Feighner had a long standing association with PCSD which led to the merger of PCSD and Feighner Research Institute in 2003 to form PCSD~Feighner Research. Together, PCSD-Feighner Research and Feighner Research Institute have conducted over 300 clinical trials in the field of psychopharmacology.
PCSD~Feighner Research is dedicated to conducting clinical trials with the highest ethical and clinical standards. Our Investigators are Board Certified Psychiatrists who are supported by highly trained Research Coordinators and Research Assistants. We carefully select subjects for our standards to ensure quality research data and to protect the safety and well being of our subjects. PCSD~Feighner Research has established guidelines for routine Good Clinical Practice (GCP) and Regulatory Compliance Review to ensure that we maintain standards that conform to the ever changing regulatory environment. Our manual of Standard Operating Procedures (SOP’s) is available on our website.
FREQUENTLY ASKED QUESTIONS
Clinical drug trials are research studies conducted in patient populations to evaluate the safety and effectiveness of investigational medications and/or uses for existing medications.
A participant is given an Informed Consent Agreement, which provides a detailed explanation of the nature and the purpose of the study. A copy of the Experimental Subject’s Bill of Rights is also provided. Studies may last from a few weeks to several months. Study participants are evaluated and monitored by our physicians and clinical staff at frequent intervals. Physical examinations and laboratory tests may be required periodically throughout the study period. All study-related visits and/or procedures are entirely cost-free. In fact, some studies even provide funds for travel and related expenses.
Services usually include laboratory tests, electrocardiograms (EKG’s), physical examinations, and visits with one of our study physicians at no cost to you. Other benefits include the health information derived from laboratory results and the evaluation of your general physical and mental health. If needed, you will receive referrals for additional treatment.
Your medical records are confidential. The patient’s name is removed from the study results. Participants are identified by a numerical coding system. The drug company of the FDA may access medical records, in order to verify data collected. Only at your request and only with your permission, your personal physician can be contacted about your participation in the study, and a summary of findings will be provided for your continuing care.
If you are interested in learning more about the Clinical Trials conducted by PCSD-Feighner Research you may call 619-692-1003, e-mail us at pcsd-fri.net or complete and return the following form and we will contact you.
- Children and Teens with Tourette’s , Ages 6-17
- Adults with Tourette’s, Ages 18-64
- Childhood Depression, Ages 6-11
- Children and Teens with Autism , Ages 5-17
Research Physicians and Clinical Staff
Michael E. McManus, M.D., Director
Robynn Cavaliere, DNP, PMHNP-BC
Clinical Research Coordinator
- Anxiety Disorders, including OCD
- Asperger’s Syndrome
- Binge Eating
- Bipolar Disorder
- Clinical Depression
- Pervasive Development Disorder
- Schizophrenia in Children and Adolescents
- Tardive Dyskinesia
- Tourette’s Syndrome
VALUED SPONSORS & CROs
- Astra Zeneca
- Bristol Myers Squibb
- Cognitive Research Corporation
- Eli-Lilly & Company
- Forest Laboratories
- Glaxo Smith Kline
- Icon Clinical Research
- McNeil PPC
- Pfizer Inc.
- PRA International
- Premier Research
- Sanofi Aventis
- Shire Pharmaceuticals
- Somerset Pharmaceuticals